T he prevalence of type 2 diabetes mellitus is rapidly increasing. Myocardial dysfunction may be a consequence of diabetic cardiomyopathy and it contributes to the poor prognosis of diabetic patients.
Introduction
Type 2 diabetes mellitus is a major risk factor for ischaemic heart disease and may cause cardiomyopathy. 1 Heart failure has a worse prognosis in diabetic than in non-diabetic patients. 2 Evidence of diastolic dysfunction appears early in the natural history of type 2 diabetes mellitus 3 and evidence of impaired systolic function may subsequently become apparent. 4 Even a mild degree of diastolic dysfunction has prognostic impact. 5 Accordingly, there is a need for a sensitive and easily applied technique for the detection and follow-up of myocardial dysfunction in the diabetic patient before clinical evidence of compromised cardiac function is apparent. This has not been achieved by traditional twodimensional echocardiography or Doppler-based studies of mitral inflow pattern.
Tissue Doppler imaging during stress is a sensitive technique for diagnosing significant coronary artery disease 6 and for the identification of patients at risk for myocardial dysfunction. 7, 8 This technique has, to the best of our knowledge, not previously been systematically evaluated in a diabetic population with respect to the possibility of detecting early signs of myocardial dysfunction in individual patients. Tissue Doppler imaging could become a valuable tool for screening diabetic populations if found to be reliable. It could also be of value in measuring improvement following various interventions. 7 This study was undertaken to test the hypothesis that tissue Doppler imaging would be a suitable tool for the early detection and quantification of myocardial dysfunction in diabetic patients.
Material and methods

Study population
We planned to choose patients who were representative of ORIGINAL ARTICLE Tissue Doppler imaging for the detection and quantitation of myocardial dysfunction in patients with type 2 diabetes mellitus diabetic and non-diabetic patients in the age group from 45 to 75 years. A total of 33 patients without diabetes, serving as controls, and 43 patients with type 2 diabetes were recruited from subjects attending the cardiology and diabetes outpatient clinics. Both groups contained a similar percentage of patients with and without previously known coronary artery disease. This was defined as a history of myocardial infarction or revascularisation, significant coronary atherosclerosis revealed by a coronary angiogram, or an abnormal dobutamine stress echocardiogram showing ST-segment depression or new or worsened wall motion abnormalities.
Age-matched subgroups (n=12) without evidence of coronary artery disease were selected from both groups. Importantly, all patients and controls had normal left ventricular global systolic function as evaluated by traditional twodimensional echocardiography. The following conditions served as exclusion criteria: clinically significant valvular heart disease, recent myocardial infarction or unstable angina, any clinical sign of heart failure, severe arrhythmia, obstructive airways disease and severe renal disease.
Stress testing
All participants were subjected to pharmacological stress with dipyridamole (0.84 mg/kg over six minutes and/or dobutamine (in incremental doses from 10-40 µg/kg/min). Myocardial velocities were recorded by tissue Doppler before infusion of the pharmacological agent and during the maximum dose. Worsening angina, ST-segment depressions and new or worsened wall motion abnormalities were considered end points. Heart rate and blood pressure were recorded during each step of the stress protocol. From these measurements, the pulse pressure was calculated as a sign of vascular distensibility and the rate pressure product (beats/min x mmHg) was calculated as an expression of oxygen demand.
Glycosylated haemoglobin (HbA 1C ) was analysed by high-performance liquid chromatography on capillary blood applied on filter paper, with an upper normal limit of 5.3% (Boehringer Mannheim Scandinavian AB, Bromma, Sweden).
Tissue Doppler
Pulsed tissue Doppler imaging was performed by investigators who were blinded to all clinical data and who employed a technique previously described in detail using a commercially available ultrasound system (Vingmed System Five, GE-Vingmed, Horten, Norway) with a 2.5 MHz transducer. 6, 9 The gain was minimised to its optimum to reduce noise artefacts. The Doppler sampling gate (8 mm) was positioned in the very basal part of each left ventricular wall in three apical views to record regional velocity curves from the septal, anteroseptal, anterior, lateral, posterior and inferior walls, respectively. Velocity curves were analysed on-line and were digitally stored for further off-line analysis.
The following parameters were taken as the average value from three consecutive cardiac cycles: peak systolic velocity (Vs), peak early diastolic (Ve) and late diastolic (Va) velocities in cm/sec, to be expressed as global myocardial function by calculating the average value from all six regions at systole and early and late diastole, respectively.
Statistics
A standard statistical programme, SPSS version 11.5(©SPSS Inc. 2002, Chicago, Illinois, US), was used for statistical analysis. Tissue Doppler data were expressed as means + standard deviation. The significance of the difference of means was tested by t-test for independent samples. The distribution of continuous variables was assessed for normality, and standard deviation was used as a measure of dispersion.
A two-tailed model was used and a p value <0.05 was considered to be statistically significant.
The Pearson correlation was used to measure the strength of a linear relationship between various continuous variables.
The study protocol was approved by the ethics committee of the Karolinska Institute and the investigation conformed to principles outlined in the Declaration of Helsinki. All participants gave their informed consent.
Results
Clinical characteristics
Pertinent clinical patient characteristics are outlined in table 1. The mean duration of diabetes in the diabetic subgroup was 7.6+7.0 years and the HbA 1C was 6.8+1.4%. Microvascular complications were distributed as follows: mild albuminuria (n=5); mild peripheral neuropathy (n=6); mild-to-moderate retinopathy (n=12); and severe retinopathy (n=1). Antidiabetic therapy was based on oral drugs in 77% of patients (metformin n=27; sulphonylurea n=17) while 51% were taking insulin. A history of chest pain was less frequent (44% vs. 73%) and of hypertension more frequent (61% vs. 27%) in the diabetic patients. Otherwise demographic data, risk factors, cardiovascular disorders and the distribution of prescribed cardiovascular drugs were similar in the two groups and in their subgroups without coronary artery disease.
Haemodynamic parameters at rest and during dipyridamole and dobutamine stress are reported in table 2. At rest, diabetic patients had a higher heart rate (p<0.03) and systolic blood pressure (p<0.05) and, therefore, an increased rate pressure product and pulse pressure (p<0.01). Systolic blood pressure and its derived values remained increased in the diabetic group during dipyridamole stress. During dobutamine stress, diastolic blood pressure was decreased in the diabetic group.
In the subgroups without coronary artery disease, the diabetic individuals demonstrated a trend towards an increased systolic blood pressure (139+20 vs. 127+14 mmHg, p<0.09) associated with an increased rate pressure product (9,680+2,272 vs. 7,823+1,844 mmHg sec -1 , p<0.05) and pulse pressure (60+16 vs. 44+13 mmHg, p<0.02). 1 ). There were weak but significant inverse correlations between resting Ve and age (p<0.05) in both groups. Among individuals without evidence of coronary artery disease, these correlations became tighter and were shifted upwards to a higher Ve per given age (control, r=0.70; p<0.01; Ve = -0.15 years + 18.95: diabetes r=0.64, p<0.05; Ve = -0.14 years + 17.47 cm/s; figure 2 ).
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In the diabetic subgroup without coronary artery disease, the effects of associated hypertension were assessed as follows: the six patients without hypertension had a mean age of 62 years and a mean Ve of 9.0 cm/s, compared to values of 54 years and 10.6 cm/s respectively in the hypertensive individuals (n=6). When calculating age-corrected Ve by assuming 58 years of age for each individual and by applying the above regression equation (Ve = -0.14 years + 17.47 cm/s), Ve was 9.4±0.7 cm/s in the non-hypertensive versus 9.8+1.8 cm/s in the hypertensive individuals with type 2 diabetes but without coronary artery disease.
Discussion
The main finding of this investigation is that quantitative, pulsed tissue Doppler imaging appears to be a valuable technique for the early detection of diastolic and systolic dysfunction in patients with type 2 diabetes. This technique revealed quantitative signs of diastolic dysfunction at rest and evidence of impaired myocardial response at systole and early diastole during dobutamine stress in patients with 
Tissue Doppler
The ultrasound methods used in this study were chosen so that we could evaluate a quantitative technique suitable for early detection of myocardial diastolic dysfunction in diabetic patients at rest and during stress and for measuring improvement following pharmacological therapy. This obviously requires the measurement of a parameter which changes unimodally with increasing dysfunction. Even though the traditional parameters of Doppler, the mitral inflow pattern, allow detection of mild diastolic dysfunction, 3,4,10,11 they give inconclusive results when evaluating the effects of therapy because moderate diastolic dysfunction presents like normal diastolic function with these bimodally reacting parameters. 12 Thus, we chose not to use traditional parameters of mitral inflow but instead to test pulsed tissue Doppler, which has been reported to demonstrate unidirectional changes with increasing myocardial dysfunction 7 besides its truly quantitative nature as a measure of myocardial velocities. We prefer to use pulsed tissue Doppler for quantification of myocardial function, as it allows on-line analysis of peak velocities by caliper and yields optimal time resolution and velocity calculation (Fast Fourier). 6 It may also be possible to acquire two-dimensional colour Doppler images at very high frame rates (> 120 frames per second) and subsequently to use off-line, computer-based analysis of the regional myocardial velocity, which will yield intrinsically lower velocities by 1.6+1.8 cm/s. 13 Thus, for sequential studies of myocardial function, each echo laboratory should be consistent in its way of recording and analysing data, either directly from pulsed Doppler curves or off-line from high frame rate colour Doppler images.
Patient selection
The present study population was a sample of patients with known diabetes mellitus without any clinical signs of heart failure and without signs of systolic left ventricular dysfunction on standard echocardiography. That hypertension was rather common was unavoidable considering the nature of diabetes. 14 Although diabetes was associated with significantly reduced diastolic velocity also in the subgroups without evidence of coronary artery disease, this was not due to the associated effects of hypertension. Those with arterial hypertension had virtually identical, if not higher, values for agecorrected diastolic velocity compared to the non-hypertensive individuals.
Chest pain is less common in diabetic than in non-diabetic patients with coronary artery disease because the more prevalent autonomic dysfunction in such patients causes less accurate pain perception and increases the likelihood of silent myocardial ischaemia. This was an important reason to apply a dobutamine stress echocardiogram before the final classification into those with and without coronary artery disease.
If we had used hypertension and chest pain as exclusion criteria, it would have created a very restricted subgroup of diabetic patients. Since the objective of this study was to evaluate a technique for early detection of myocardial dysfunction in commonly seen diabetic patients, it was considered correct to keep the diabetic population as genuine and unselected as possible. The exclusion criteria used were applied to rule out ongoing cardiac diseases (recent myocardial infarction, unstable angina and significant valvular disease), conditions that could hamper the investigations (obstructive airway disease) or concomitant end-stage disease.
Diastolic dysfunction
For clinical use, diastolic dysfunction may be divided into three stages: mild, that is abnormal relaxation; moderate, that is pseudonormal filling pattern; and severe, that is restrictive filling of the left ventricle. 12, 15 Diastolic dysfunction is usually observed in patients with older age, arterial hypertension, coronary heart disease and diabetes. 10, 16, 17 It is common and has been found in 21% of a general population where the prevalence of clinical heart failure was not more than 2.2%. 18 Interestingly, the prevalence of diastolic dysfunction is much higher (60%) in diabetic subjects without heart failure despite adequate metabolic control, as shown by our data and earli-ORIGINAL ARTICLE
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DIABETES AND VASCULAR DISEASE RESEARCH er work. 10, 11 Nevertheless, even mild diastolic dysfunction is associated with a doubling of the risk for cardiovascular death. 5 There is increasing evidence that predominantly diastolic myocardial dysfunction accounts for more than 50% of patients > 65 years admitted for heart failure. 19 But evidence-based medicine still lacks studies of effective treatment of diastolic heart failure. This may be partly due to the methodological problems and inconclusive results yielded by the traditionally assessed mitral inflow pattern. Therefore, the development of tissue Doppler imaging in the last decade as a quantitative measure of myocardial function has been timely, in particular as it has been shown to be a sensitive, specific and superior method to traditional echocardiography for diagnosis and quantification of systolic and diastolic dysfunction. 7, 8, 13, 20, 21 Early and late diastolic function In the present study, myocardial velocity was diminished during early diastole and enhanced during late diastole in patients with type 2 diabetes. It is possible that in this early stage of diastolic dysfunction, some increase of late diastolic filling counterbalances the reduction in early diastolic relaxation properties in the diabetic myocardium so that total left ventricular filling and ejection are maintained. 20 The particular advantage of pulsed tissue Doppler is the direct measurement of early and late diastolic velocities, which reflect the quality of myocardial action at these particular times in the cardiac cycle. Indeed, these direct velocities should be used for evaluation of diastolic function more than the Ve/Va ratio, which is a non-diagnostic calculation and as such does not indicate if the velocities involved are at a normal or a reduced level. Furthermore, the Ve/Va ratio reflects a bimodal way of changes in the course of diastolic dysfunction, as it will return towards normal when the patient has severe dysfunction, when atrial contraction has deteriorated as well.
The magnitude of early diastolic velocity is inversely correlated with age. This is a well-known observation in normal individuals. 22 Due to the considerable loss of velocity in the process of normal ageing (-1.5 cm/s during every decade), normal values need to be defined individually with respect to age. We recommend that measurements higher than Ve = -0.15 years + 18 cm/s (the dotted line in figure 2 ) should be regarded as normal and lower values as abnormal. Using this criterion, our control group had 13/14 /(93%) individuals with normal diastolic function. The subgroups with coronary artery disease, diabetes or both had 12/19 (63%), 6/12 (50%) and 21/31 (68%) patients, respectively, with abnormal diastolic function; this is comparable to reports based on traditional Doppler echocardiography using time-consuming Valsalva manoeuvres in order to unmask pseudonormal filling patterns. 10, 11 Stress test Tissue Doppler imaging detected diastolic dysfunction at rest and during dobutamine stress. This is concordant with previous studies showing that tissue Doppler imaging in nondiabetic subjects and in patients with type 1 diabetes is a valuable tool to measure the velocity response of healthy and diseased myocardial segments, both at rest and during pharmacological stress. 6, 9, 23, 24 In the present study, type 2 diabetes patients demonstrated a blunted response to dobutamine stress in both systolic and early diastolic velocities. This observation is in agreement with reports on reduced stress tolerance 25 and on impaired sympathetic cardiac innervation, 26 but not with a recent report on normal response of the diabetic heart to catecholamine stress. 27 However, the results from this last study reflect the effects of high heart rates from a combined atropine and dobutamine stress protocol (140+11 sec -1 ) at peak stress compared to the moderately increased heart rate of 116+19 sec -1 in the present study without use of atropine.
Clinical implications
The exact mechanism of myocardial dysfunction in diabetics is unknown. Abnormalities in glucose metabolism independently influence myocardial function 28 but hypertension, silent ischaemia, autonomic nervous dysfunction, oxygen free radical formation and microvascular abnormalities have also been suggested as causal factors. Diastolic dysfunction may be a consequence of diabetic cardiomyopathy and is an important influencing factor in the poor prognosis of patients with diabetes mellitus. 29 Early risk stratification and application of appropriate therapy in diabetics is indicated as early as possible in order to improve their prognosis.
We conclude that tissue Doppler imaging is an easily applied and important tool to detect myocardial abnormalities in diabetics. Likewise, it may be a useful tool in pharmacological studies aimed at the prevention and treatment of diabetic cardiomyopathy.
